Remission InductionRemission, SpontaneousHematologic NeoplasmsTreatment OutcomeRecurrenceLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsCytarabinePrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisNeoplasmsLeukemiaFollow-Up StudiesCyclophosphamideCombined Modality TherapyRetrospective StudiesAntineoplastic AgentsVincristineLymphomaPrednisoneLymphoma, Non-HodgkinTransplantation, AutologousLeukemia, MyeloidLeukemia, LymphoidTime FactorsBone Marrow TransplantationHematopoietic Stem Cell TransplantationMethotrexateDaunorubicinPrednisoloneHodgkin DiseaseDisease-Free SurvivalSurvival AnalysisTransplantation, HomologousImmunosuppressive AgentsSurvival RateDrug Administration ScheduleNeoplasms, Second PrimaryBone MarrowAcute DiseaseNeoplasm, ResidualDoxorubicinNephrotic SyndromeAntibodies, Monoclonal, Murine-DerivedAntirheumatic AgentsAntibodies, MonoclonalProspective StudiesMultiple MyelomaColitis, UlcerativeMesalamineDrug Therapy, CombinationEtoposideSalvage TherapyLymphoma, B-CellLeukemia, Promyelocytic, AcuteThioguanineAsparaginase6-MercaptopurineTransplantation ConditioningDisease ProgressionMyelodysplastic SyndromesLeukemia, Lymphocytic, Chronic, B-CellTumor Markers, BiologicalSeverity of Illness IndexGraft vs Host DiseaseCrohn DiseaseIdarubicinVidarabineArthritis, RheumatoidLeukemia, Myelogenous, Chronic, BCR-ABL PositiveNeoplasm StagingNeoplasm Recurrence, LocalCladribineRisk FactorsGenital Neoplasms, FemaleCell Line, TumorClinical Trials as TopicBiopsyWegener GranulomatosisOvarian NeoplasmsTomography, X-Ray ComputedWhole-Body IrradiationMelphalanLung NeoplasmsDepressive Disorder, MajorCohort StudiesTranslocation, GeneticGastrointestinal NeoplasmsPredictive Value of TestsSensitivity and SpecificityDose-Response Relationship, DrugAzathioprineBurkitt LymphomaLymphoma, FollicularBreast NeoplasmsBleomycinProcarbazineNeoplasm ProteinsLeukemia, B-CellPituitary ACTH Hypersecretion